BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38787429)

  • 1. A predictive model using MRI and clinicopathologic features for breast cancer recurrence in young women treated with upfront surgery.
    Chae EY; Jung MR; Cha JH; Shin HJ; Choi WJ; Kim HH
    Eur Radiol; 2024 May; ():. PubMed ID: 38787429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preoperative prediction of HER-2 expression status in breast cancer based on MRI radiomics model].
    Zhang Y; Huang H; Yin L; Wang ZX; Lu SY; Wang XX; Xiang LL; Zhang Q; Zhang JL; Shan XH
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):428-437. PubMed ID: 38742356
    [No Abstract]   [Full Text] [Related]  

  • 3. Invasive Breast Cancer: Prognostic Value of Peritumoral Edema Identified at Preoperative MR Imaging.
    Cheon H; Kim HJ; Kim TH; Ryeom HK; Lee J; Kim GC; Yuk JS; Kim WH
    Radiology; 2018 Apr; 287(1):68-75. PubMed ID: 29315062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of tumor recurrence after surgical resection of ampullary adenocarcinoma using magnetic resonance imaging.
    Lee S; Lee JE; Kim KD; Hwang JA; Choi SY; Moon JE; Kim MJ
    Eur Radiol; 2024 Mar; ():. PubMed ID: 38536460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microcalcifications and Peritumoral Edema Predict Survival Outcome in Luminal Breast Cancer Treated with Neoadjuvant Chemotherapy.
    Kwon BR; Shin SU; Kim SY; Choi Y; Cho N; Kim SM; Yi A; Yun B; Jang M; Ha SM; Lee SH; Chang JM; Moon WK
    Radiology; 2022 Aug; 304(2):310-319. PubMed ID: 35536129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The added value of ultrasound imaging biomarkers to clinicopathological factors for the prediction of high-risk Oncotype DX recurrence scores in patients with breast cancer.
    Luo Y; Gao Y; Niu Z; Zhang J; Liu Z; Zhang Y; Shen S; Jiang Y; Xiao M; Zhu Q
    Quant Imaging Med Surg; 2024 May; 14(5):3519-3533. PubMed ID: 38720854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric MRI-based radiomics nomogram for preoperative prediction of lymphovascular invasion and clinical outcomes in patients with breast invasive ductal carcinoma.
    Zhang J; Wang G; Ren J; Yang Z; Li D; Cui Y; Yang X
    Eur Radiol; 2022 Jun; 32(6):4079-4089. PubMed ID: 35050415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma.
    Jones GD; Brandt WS; Shen R; Sanchez-Vega F; Tan KS; Martin A; Zhou J; Berger M; Solit DB; Schultz N; Rizvi H; Liu Y; Adamski A; Chaft JE; Riely GJ; Rocco G; Bott MJ; Molena D; Ladanyi M; Travis WD; Rekhtman N; Park BJ; Adusumilli PS; Lyden D; Imielinski M; Mayo MW; Li BT; Jones DR
    JAMA Surg; 2021 Feb; 156(2):e205601. PubMed ID: 33355651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development and validation of a predictive model for recurrence in rectal cancer based on radiological and clinicopathological data.
    Yeo DM; Oh SN; Lee MA; Lee IK; Lee YS; Oh ST; Lee SH; Park MS; Yim HW
    Eur Radiol; 2021 Nov; 31(11):8586-8596. PubMed ID: 33945023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Affecting Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: Development and Validation of a Predictive Nomogram.
    Kim SY; Cho N; Choi Y; Lee SH; Ha SM; Kim ES; Chang JM; Moon WK
    Radiology; 2021 May; 299(2):290-300. PubMed ID: 33754824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single Hepatocellular Carcinoma: Preoperative MR Imaging to Predict Early Recurrence after Curative Resection.
    An C; Kim DW; Park YN; Chung YE; Rhee H; Kim MJ
    Radiology; 2015 Aug; 276(2):433-43. PubMed ID: 25751229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-based multiregional radiomics for preoperative prediction of tumor deposit and prognosis in resectable rectal cancer: a bicenter study.
    Li H; Chen XL; Liu H; Liu YS; Li ZL; Pang MH; Pu H
    Eur Radiol; 2023 Nov; 33(11):7561-7572. PubMed ID: 37160427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of a risk assessment tool for the personalized screening of breast cancer in Chinese populations: A prospective cohort study.
    Zhu J; Wang L; Gong W; Li X; Wang Y; Zhu C; Li H; Shi L; Yang C; Du L
    Cancer; 2024 Apr; 130(S8):1403-1414. PubMed ID: 37916832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A predictive model for recurrence after upfront surgery in patients with resectable pancreatic ductal adenocarcinoma (PDAC) by using preoperative clinical data and CT characteristics.
    Tian N; Wu D; Zhu L; Zeng M; Li J; Wang X
    BMC Med Imaging; 2022 Jul; 22(1):116. PubMed ID: 35786426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of MRI-based radiomics model to predict recurrence risk in patients with endometrial cancer: a multicenter study.
    Lin Z; Wang T; Li Q; Bi Q; Wang Y; Luo Y; Feng F; Xiao M; Gu Y; Qiang J; Li H
    Eur Radiol; 2023 Aug; 33(8):5814-5824. PubMed ID: 37171486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG metabolic parameter-based models for predicting recurrence after upfront surgery in synchronous colorectal cancer liver metastasis.
    Lee HS; Kwon HW; Lim SB; Kim JC; Yu CS; Hong YS; Kim TW; Oh M; Han S; Oh JH; Park S; Kim TS; Kim SK; Kim HJ; Kwak JY; Oh HS; Kim S; Kwak JM; Lee JS; Kim JS
    Eur Radiol; 2023 Mar; 33(3):1746-1756. PubMed ID: 36114846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Nomogram Based on Hematological Parameters and Clinicopathological Characteristics for Predicting Local-Regional Recurrence After Breast-Conserving Therapy.
    Sun L; Zhao W; Wang F; Song X; Wang X; Li C; Yu Z
    Front Oncol; 2022; 12():861210. PubMed ID: 35928880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging phenotypes and features associated with pathogenic mutation to predict recurrence or metastasis in breast cancer.
    Shao Z; Yu J; Cheng Y; Ma W; Liu P; Lu H
    BMC Cancer; 2023 Jan; 23(1):97. PubMed ID: 36707770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction.
    Ning L; Liu Y; He X; Han R; Xin Y; Zhao J; Liu X
    Am J Clin Oncol; 2024 May; 47(5):228-238. PubMed ID: 38131531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.